Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 -3.034M
June 30, 2026 -3.924M
March 31, 2026 -3.40M
December 31, 2025 -2.436M
September 30, 2025 -2.51M
June 30, 2025 -2.948M
March 31, 2025 -3.47M
December 31, 2024 -2.254M
September 30, 2024 -2.936M
June 30, 2024 -4.61M
March 31, 2024 -2.883M
December 31, 2023 -3.949M
September 30, 2023 -2.96M
June 30, 2023 -5.333M
March 31, 2023 -5.25M
December 31, 2022 -5.413M
September 30, 2022 -5.238M
June 30, 2022 -8.746M
March 31, 2022 -8.934M
December 31, 2021 -8.004M
September 30, 2021 -3.943M
June 30, 2021 -8.347M
March 31, 2021 -9.708M
December 31, 2020 -6.327M
September 30, 2020 -8.124M
Date Value
June 30, 2020 -9.69M
March 31, 2020 -14.36M
December 31, 2019 -14.16M
September 30, 2019 -11.47M
June 30, 2019 -12.32M
March 31, 2019 -13.24M
December 31, 2018 -8.99M
September 30, 2018 -6.301M
June 30, 2018 -6.41M
March 31, 2018 -7.374M
December 31, 2017 -6.676M
September 30, 2017 -6.784M
June 30, 2017 -8.77M
March 31, 2017 -7.535M
December 31, 2016 -10.32M
September 30, 2016 -4.613M
June 30, 2016 -8.238M
March 31, 2016 -6.229M
December 31, 2015 6.995M
September 30, 2015 -5.51M
June 30, 2015 -10.69M
March 31, 2015 -10.75M
December 31, 2014 -8.921M
September 30, 2014 -5.592M
June 30, 2014 -9.811M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Relmada Therapeutics, Inc. -12.59M
Journey Medical Corp. -3.437M
ANI Pharmaceuticals, Inc. 83.79M
Corcept Therapeutics, Inc. 142.89M
Veru, Inc. -5.467M